Dosing angiotension II blockers - Beyond blood pressure

Nephrology Dialysis Transplantation

Volumn 14, Issue 11, 1999, Pages 2568-2570

  Peters, Harm ^a   Ritz, Eberhard ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiotension II; Fibrosis; TGF

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FIBRONECTIN; HYDRALAZINE; LISINOPRIL; LOSARTAN; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN; SODIUM; TRANSFORMING GROWTH FACTOR BETA; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BALANCE; ANIMAL; BLOOD PRESSURE; DISEASE COURSE; DRUG ANTAGONISM; EDITORIAL; PATHOPHYSIOLOGY;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY DISEASES; RECEPTORS, ANGIOTENSIN;

EID: 0033237251     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.11.2568     Document Type: Article

References (18)

1. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy
2. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy
3. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
4. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
5. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
6. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
7. Is the antiproteinuric effect of ACE inhibition mediated by interference in the reninangiotensin system?
8. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An updated meta-analysis
9. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study
10. Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease
11. Molecular mechanisms of angiotensin II in the kidney: Emerging role in the progression of renal disease: Beyond haemodynamics
12. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor
13. Renal injury from angiotensin II-mediated hypertension
14. Pathophysiology of progressive nephropathies
15. Targeting TGF-beta over-expression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade
16. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions
17. Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function
18. Antiproteinuric effect of Losartan in patients with chronic renal diseases